Axcynsis Therapeutics Appoints Emeritus Professor Paul Herrling to its Scientific Advisory Board
Apr 04, 2023 - Singapore Biotech Axcynsis Therapeutics Strengthens [...]
Official opening of Axcynsis Therapeutics’ office and research facility in Shanghai China
Jan 06, 2023 – Singapore-based biotech start-up Axcynsis Therapeutics [...]
Axcynsis Therapeutics awarded TOP 5 Biotech Startups in Singapore 2022
Dec 27, 2022 – Axcynsis Therapeutics has been awarded [...]
Axcynsis Therapeutics selected as 2022 TOP 50 Health Tech Startups in Southeast Asia
Listed as part of the 2022 Southeast Asia Health [...]
Official opening of Axcynsis Therapeutics’ office and research facility in Singapore
Sep 1, 2022 – Singapore-based biotech start-up, Axcynsis Therapeutics, [...]
Tetris Therapeutics Announces Name Change to Axcynsis Therapeutics
July 20, 2022 – Singapore-based biotech start-up, Tetris Therapeutics [...]
Tetris Therapeutics raises US$15 million in seed funding to revolutionize targeted cancer treatments
One of the largest seed funds raised by a [...]